|
Hypertension
Citations 211-220 of 260 total displayed.
|
Past content
(since Mar 1998):
|
- Scientific Review and Clinical Applications
Interventions to Enhance Patient Adherence to Medication Prescriptions: Scientific Review
- Heather P. McDonald; Amit X. Garg; R. Brian Haynes
JAMA 2002; 288: 2868-2879.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney Disease: Results From the AASK Trial
- Jackson T. Wright Jr; George Bakris; Tom Greene; Larry Y. Agodoa; Lawrence J. Appel; Jeanne Charleston; DeAnna Cheek; Janice G. Douglas-Baltimore; Jennifer Gassman; Richard Glassock; Lee Hebert; Kenneth Jamerson; Julia Lewis; Robert A. Phillips; Robert D. Toto; John P. Middleton; Stephen G. Rostand; for the African American Study of Kidney Disease and Hypertension Study Group
JAMA 2002; 288: 2421-2431.
[Abstract]
[Full text]
[PDF]
- Editorials
Hypertension Control and Kidney Disease: Some Questions Answered, Many Remain
- Michael H. Alderman
JAMA 2002; 288: 2466-2467.
[Extract]
[Full text]
[PDF]
- JAMA Patient Page
Hypertensive Kidney Disease
-
JAMA 2002; 288: 2498.
[PDF]
[ Key Words ]
- Special Communications
Primary Prevention of Hypertension: Clinical and Public Health Advisory From the National High Blood Pressure Education Program
- Paul K. Whelton; Jiang He; Lawrence J. Appel; Jeffrey A. Cutler; Stephen Havas; Theodore A. Kotchen; Edward J. Roccella; Ron Stout; Carlos Vallbona; Mary C. Winston; Joanne Karimbakas; for the National High Blood Pressure Education Program Coordinating Committee
JAMA 2002; 288: 1882-1888.
[Abstract]
[Full text]
[PDF]
- Special Communications
Exercise Training and the Cardiovascular Consequences of Type 2 Diabetes and Hypertension: Plausible Mechanisms for Improving Cardiovascular Health
- Kerry J. Stewart
JAMA 2002; 288: 1622-1631.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Effects of Losartan on Cardiovascular Morbidity and Mortality in Patients With Isolated Systolic Hypertension and Left Ventricular Hypertrophy: A Losartan Intervention For Endpoint Reduction (LIFE) Substudy
- Sverre E. Kjeldsen; Björn Dahlöf; Richard B. Devereux; Stevo Julius; Peter Aurup; Jonathan Edelman; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H. Lindholm; Markku S. Nieminen; Per Omvik; Suzanne Oparil; Steven Snapinn; Hans Wedel; for the LIFE Study Group
JAMA 2002; 288: 1491-1498.
[Abstract]
[Full text]
[PDF]
- Scientific Review and Clinical Applications
New Evidence for Stroke Prevention: Scientific Review
- Sharon E. Straus; Sumit R. Majumdar; Finlay A. McAlister
JAMA 2002; 288: 1388-1395.
[Abstract]
[Full text]
[PDF]
- Contempo Updates
Contemporary Concepts of the Pathogenesis and Management of Preeclampsia
- Kristine Y. Lain; James M. Roberts
JAMA 2002; 287: 3183-3186.
[Extract]
[Full text]
[PDF]
- Original Contributions
Cost-effectiveness of Intensive Glycemic Control, Intensified Hypertension Control, and Serum Cholesterol Level Reduction for Type 2 Diabetes
- The CDC Diabetes Cost-effectiveness Group
JAMA 2002; 287: 2542-2551.
[Abstract]
[Full text]
[PDF]
|
|
